Literature DB >> 12377547

Strategic emphases for tropical diseases research: a TDR perspective.

Jan H F Remme, Erik Blas, Lester Chitsulo, Philippe M P Desjeux, Howard D Engers, Thomas P Kanyok, Jane F Kayondo, Deborah W Kioy, Vasanthapuram Kumaraswami, Janis K Lazdins, Paul P Nunn, Ayoade Oduola, Robert G Ridley, Yeya T Toure, Fabio Zicker, Carlos M Morel.   

Abstract

Setting priorities for health research is a difficult task, especially for the neglected diseases of the poor. A new approach to priority setting for tropical diseases research has been adopted by the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (known as the TDR). Priorities are defined on the basis of a comprehensive analysis of research needs and research opportunities for each of the ten major tropical diseases in the TDR portfolio. The resulting strategic emphases matrix reflects the priorities for tropical diseases research from the perspective of the TDR. Its purpose is not to impose global research priorities, but we believe the results could be useful to other organizations.

Mesh：

Year:  2002        PMID： 12377547     DOI： 10.1016/s0966-842x(02)02431-9

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


  7 in total

1.  Product R&D for neglected diseases. Twenty-seven years of WHO/TDR experiences with public-private partnerships.

Authors:  Robert G Ridley
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

2.  Antiplasmodial and antitrypanosomal activity of plants from the Kingdom of Saudi Arabia.

Authors:  Essam Abdel-Sattar; Fathalla M Harraz; Soliman M A Al-Ansari; Sahar El-Mekkawy; Chikara Ichino; Hiroaki Kiyohara; Kazuhiko Otoguro; Satoshi Omura; Haruki Yamada
Journal:  J Nat Med       Date:  2008-12-10       Impact factor: 2.343

3.  Comparisons of mutants lacking the Golgi UDP-galactose or GDP-mannose transporters establish that phosphoglycans are important for promastigote but not amastigote virulence in Leishmania major.

Authors:  Althea A Capul; Suzanne Hickerson; Tamara Barron; Salvatore J Turco; Stephen M Beverley
Journal:  Infect Immun       Date:  2007-07-02       Impact factor: 3.441

4.  Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011.

Authors:  Yanina Balabanova; Andreas Gilsdorf; Silke Buda; Reinhard Burger; Tim Eckmanns; Barbara Gärtner; Uwe Gross; Walter Haas; Osamah Hamouda; Johannes Hübner; Thomas Jänisch; Manfred Kist; Michael H Kramer; Thomas Ledig; Martin Mielke; Matthias Pulz; Klaus Stark; Norbert Suttorp; Uta Ulbrich; Ole Wichmann; Gérard Krause
Journal:  PLoS One       Date:  2011-10-04       Impact factor: 3.240

5.  A research and development agenda for the control and elimination of human helminthiases.

Authors:  Jürg Utzinger
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

6.  Cheminformatics models for inhibitors of Schistosoma mansoni thioredoxin glutathione reductase.

Authors:  Sonam Gaba; Salma Jamal; Vinod Scaria
Journal:  ScientificWorldJournal       Date:  2014-11-25

7.  Antitrypanosomal Activities and Mechanisms of Action of Novel Tetracyclic Iridoids from Morinda lucida Benth.

Authors:  Kofi D Kwofie; Nguyen Huu Tung; Mitsuko Suzuki-Ohashi; Michael Amoa-Bosompem; Richard Adegle; Maxwell M Sakyiamah; Frederick Ayertey; Kofi Baffour-Awuah Owusu; Isaac Tuffour; Philip Atchoglo; Kwadwo K Frempong; William K Anyan; Takuhiro Uto; Osamu Morinaga; Taizo Yamashita; Frederic Aboagye; Alfred A Appiah; Regina Appiah-Opong; Alexander K Nyarko; Yasuchika Yamaguchi; Dominic Edoh; Kwadwo A Koram; Shoji Yamaoka; Daniel A Boakye; Nobuo Ohta; Yukihiro Shoyama; Irene Ayi
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.